Search research articles
Contact Us
Filters
Showing results (151-160 of 164) with videos related to
Page
of 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 26, 2005
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 12, 2024
Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors
Si-Wei Wang, Qiu-Yi Zheng, Wei-Feng Hong, et al.
Japanese Journal of Clinical Oncology
|
February 15, 2005
Radiation therapy for adrenal gland metastases from hepatocellular carcinoma
Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, et al.
Cancer Journal (Sudbury, Mass.)
|
April 25, 2006
Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients
Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, et al.
Oncotarget
|
January 12, 2017
Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus
Tian-Zhu Yu, Wen Zhang, Qing-Xin Liu, et al.
Journal of Hepatology
|
March 14, 2020
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
Nalee Kim, Jason Cheng, Inkyung Jung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 2026
Stereotactic body radiotherapy with continued first-line PD-1 inhibitor-based therapy as a resistance-overcoming strategy in oligoprogressive hepatocellular carcinoma: A prospective phase II clinical study
Shu-Jung Hsu, Yen-Cheng Chao, Si-Wei Wang, et al.
Investigational New Drugs
|
April 24, 2010
A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice
Jin-Bin Jia, Wen-Quan Wang, Hui-Chuan Sun, et al.
Advances in Radiation Oncology
|
August 22, 2025
Erratum to 'Integrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction' [Advances in Radiation Oncology (2025) 10, 101713]
Qi-Qiao Wu, Zhao-Sheng Yin, Yi Zhang, et al.
Advances in Radiation Oncology
|
March 4, 2025
Integrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction
Qi-Qiao Wu, Zhao-Sheng Yin, Yi Zhang, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 164) with videos related to
Sort By:
Page
of 17
International Journal of Radiation Oncology, Biology, Physics
|
January 26, 2005
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 12, 2024
Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors
Si-Wei Wang, Qiu-Yi Zheng, Wei-Feng Hong, et al.
Japanese Journal of Clinical Oncology
|
February 15, 2005
Radiation therapy for adrenal gland metastases from hepatocellular carcinoma
Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, et al.
Cancer Journal (Sudbury, Mass.)
|
April 25, 2006
Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients
Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, et al.
Oncotarget
|
January 12, 2017
Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus
Tian-Zhu Yu, Wen Zhang, Qing-Xin Liu, et al.
Journal of Hepatology
|
March 14, 2020
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
Nalee Kim, Jason Cheng, Inkyung Jung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 2026
Stereotactic body radiotherapy with continued first-line PD-1 inhibitor-based therapy as a resistance-overcoming strategy in oligoprogressive hepatocellular carcinoma: A prospective phase II clinical study
Shu-Jung Hsu, Yen-Cheng Chao, Si-Wei Wang, et al.
Investigational New Drugs
|
April 24, 2010
A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice
Jin-Bin Jia, Wen-Quan Wang, Hui-Chuan Sun, et al.
Advances in Radiation Oncology
|
August 22, 2025
Erratum to 'Integrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction' [Advances in Radiation Oncology (2025) 10, 101713]
Qi-Qiao Wu, Zhao-Sheng Yin, Yi Zhang, et al.
Advances in Radiation Oncology
|
March 4, 2025
Integrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction
Qi-Qiao Wu, Zhao-Sheng Yin, Yi Zhang, et al.
Page
of 17